{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:20:14Z","timestamp":1777915214392,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare outcomes of PleurX and peritoneal port for malignant ascites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective review of medical records was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting\/Subjects:<\/jats:title>\n                    <jats:p>Subjects were consecutive patients receiving PleurX or peritoneal port for malignant ascites in a center in Sydney, Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements:<\/jats:title>\n                    <jats:p>Demographic data, complication rates, hospitalization rates, and survival were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sixteen cases were analyzed: 6 had peritoneal port (170 catheter days) and 10 had PleurX (477 catheter days). Complication rates were low with both drainage systems. Cellulitis rate was 33% (1.2 events\/100 catheter days) for peritoneal port and 10% (0.2 events\/100 catheter days) for PleurX. Hospital admission days were 27 days\/100 catheter days for peritoneal port and 5.2 days\/100 catheter days for PleurX.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Both PleurX and peritoneal port seem feasible options in draining malignant ascites. Further research is needed to ascertain whether there are true differences in cellulitis\/admission rates. Patient quality of life, experience, and preference should be included in future studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jpm.2021.0504","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T16:30:05Z","timestamp":1648225805000},"page":"1127-1131","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Peritoneal Indwelling Catheters for Malignant Ascites: A Retrospective Case Series of PleurX and Peritoneal Port"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-4493","authenticated-orcid":false,"given":"Liang Yik","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Palliative Care, Concord Repatriation General Hospital, Concord, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Loneragan","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Concord Repatriation General Hospital, Concord, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-066X","authenticated-orcid":false,"given":"Jessica","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Concord Repatriation General Hospital, Concord, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Concord Repatriation General Hospital, Concord, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/026921639000400109"},{"key":"e_1_3_2_3_2","first-page":"178","article-title":"New strategies for the management of malignant ascites","volume":"4","author":"Preston N","year":"1995","unstructured":"Preston N: New strategies for the management of malignant ascites. Eur J Cancer Care, 1995; 4:178\u2013183.","journal-title":"Eur J Cancer Care"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800830104"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.177.3.1770615"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1191\/026921600676345896"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216302pm509oa"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v4.i4.87"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000337690"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2018.1461525"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3145-y"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.15.14484"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.09.008"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261864"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000136828.42612.B4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000147082.05392.2B"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2013.0427"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2019.04.006"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0453-x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/2058460115579934"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2016.04.014"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1515\/raon-2016-0002"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-016-0116-5"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jpm.2021.0504","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2021.0504","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2021.0504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:13:48Z","timestamp":1777655628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jpm.2021.0504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1089\/jpm.2021.0504"],"URL":"https:\/\/doi.org\/10.1089\/jpm.2021.0504","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}